Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study

BACKGROUND: Whether paricalcitol (PCT) reduces proteinuria in the presence of intensified inhibition of Renin-Angiotensin-System (RAS) is poorly studied. We evaluated the antiproteinuric effect of PCT in non-dialysis chronic kidney disease (CKD) patients with proteinuria greater than 0.5 g/24 h pers...

Descripción completa

Detalles Bibliográficos
Autores principales: De Nicola, Luca, Conte, Giuseppe, Russo, Domenico, Gorini, Antonio, Minutolo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511164/
https://www.ncbi.nlm.nih.gov/pubmed/23167771
http://dx.doi.org/10.1186/1471-2369-13-150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511164/
https://www.ncbi.nlm.nih.gov/pubmed/23167771
http://dx.doi.org/10.1186/1471-2369-13-150

Ejemplares similares